IGCIGC Pharma, Inc.

0.3080USD+7.96%Mkt Cap: 31.84M $P/E:

IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and …

Key Statistics

Company
Market Cap31.84M $
Enterprise Value32.57M $
Revenue (TTM)1.11M $
Gross Profit619.00K $
Net Income (TTM)-7.12M $
Revenue/Share0.0130 USD
Last Price0.3080 USD
Fiscal Year EndMar 2025
MR QuarterJun 2026
Employees70
CountryUS
SectorIndustrials
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-3.62
PEG
EV/EBITDA-4.33
EV/Revenue29.45
P/S28.79
P/B4.97
EPS (TTM)-0.06
EPS (Forward)-0.09
52W Range
0.235028% of range0.5000
52W High0.5000 USD
52W Low0.2350 USD
Profitability
Gross Margin48.70%
Oper. Margin-1050.57%
EBITDA Margin0.00%
Profit Margin-560.27%
ROE-112.50%
ROA-81.41%
Growth
Revenue Growth-19.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-4.07M $
CapEx (TTM)316.00K $
FCF Margin-227.97%
FCF Yield-7.92%
Net Debt728.00K $
Net Debt/EBITDA-0.10
Balance Sheet
Debt/Equity0.04
Current Ratio1.32
Quick Ratio0.79
Book Value/Sh0.0620 USD
Cash/Share0.0030 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:10
Split DateApr 19, 2013
Analyst Consensus
Rating
Target (Mean)4.250 USD
Upside (mean)+1279.9%
Target Range3.000 USD5.500 USD
$3.000+1279.9% to mean$5.500
# Analysts2
Ownership
Shares Out.103.38M
Float89.37M
Insiders13.51%
Institutions22.09%
Short Interest
Short Ratio1.5d
Short % Float0.88%
Short % Out.0.52%
Shares Short541.70K
Short (prev mo.)484.81K
Technical
SMA 500.2708 (+13.7%)
SMA 2000.2925 (+5.3%)
Beta0.46
S&P 52W Chg19.18%
Avg Vol (30d)675.32K
Avg Vol (10d)1.38M
Technical Indicators
RSI (14)67.6
MACD0.0073
MACD Signal0.0021
MACD Hist.+0.0053
BB Upper0.3063 USD
BB Middle0.2670 USD
BB Lower0.2277 USD
BB Width29.43%
ATR (14)0.0149 USD
Vol Ratio (20d)2.53x